Effect of a single dose (600 mg) of albendazole on Loa loa microfilaraemia
Parasite, 9 1 (2002) 59-63
Published online: 2014-09-01
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Revisiting the Loa loa microfilaremia thresholds above which serious adverse events may occur with ivermectin treatment
Charlotte Boullé, Sébastien D. Pion, Jacques Gardon, Nathalie Gardon-Wendel, Joël Fokom Domgue, Joseph Kamgno, Cédric B. Chesnais, Michel Boussinesq and Luc E. CoffengPLOS Neglected Tropical Diseases 19 (3) e0012957 (2025)
https://doi.org/10.1371/journal.pntd.0012957
Imported loiasis: Diagnostic and therapeutic challenges
C. Elouardi, A. Lefort, L. Deconinck, N. Peiffer-Smadja, S. Houzé and N. ArgyInfectious Diseases Now 55 (3) 105053 (2025)
https://doi.org/10.1016/j.idnow.2025.105053
(2025)
https://doi.org/10.1101/2025.05.22.25328128
Eosinophils, basophils and myeloid-derived suppressor cells in chronic Loa loa infection and its treatment in an endemic setting
Gerrit Burger, Rafiou Adamou, Ruth Kreuzmair, Wilfrid Ndzebe Ndoumba, Dorothea Ekoka Mbassi, Anne Marie Nkoma Mouima, Carole Mamgno Tabopda, Roukoyath Moyoriola Adegnika, Ayong More, Dearie Glory Okwu, Lia-Betty Dimessa Mbadinga, Carlos Lamsfus Calle, Luzia Veletzky, Wolfram Gottfried Metzger, Benjamin Mordmüller, Michael Ramharter, Ghyslain Mombo-Ngoma, Ayola Akim Adegnika, Rella Zoleko-Manego, Matthew B. B. McCall and Subash BabuPLOS Neglected Tropical Diseases 18 (5) e0012203 (2024)
https://doi.org/10.1371/journal.pntd.0012203
77 (2023)
https://doi.org/10.1007/978-3-031-49450-5_5
Efficacy, safety, and tolerability of albendazole and ivermectin based regimens for the treatment of microfilaraemic loiasis in adult patients in Gabon: A randomized controlled assessor blinded clinical trial
Rella Zoleko-Manego, Ruth Kreuzmair, Luzia Veletzky, Wilfrid Ndzebe-Ndoumba, Dorothea Ekoka Mbassi, Dearie G. Okwu, Lia B. Dimessa-Mbadinga-Weyat, Roselyne D. Houtsa-Temgoua, Johannes Mischlinger, Matthew B. B. McCall, Peter G. Kresmner, Selidji T. Agnandji, Betrand Lell, Ayôla A. Adegnika, Ghyslain Mombo-Ngoma, Michael Ramharter and Angela Monica IonicaPLOS Neglected Tropical Diseases 17 (8) e0011584 (2023)
https://doi.org/10.1371/journal.pntd.0011584
33 (2022)
https://doi.org/10.1002/9783527823413.ch3
Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial
Jérémy T Campillo, Paul Bikita, Marlhand Hemilembolo, et al.Clinical Infectious Diseases 75 (1) 19 (2022)
https://doi.org/10.1093/cid/ciab906
Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update
Jong-Yil Chai, Bong-Kwang Jung and Sung-Jong HongThe Korean Journal of Parasitology 59 (3) 189 (2021)
https://doi.org/10.3347/kjp.2021.59.3.189
Atypical Clinical Manifestations of Loiasis and Their Relevance for Endemic Populations
Kevin G Buell, Charles Whittaker, Cédric B Chesnais, et al.Open Forum Infectious Diseases 6 (11) (2019)
https://doi.org/10.1093/ofid/ofz417
Operationalization of the test and not treat strategy to accelerate the elimination of onchocerciasis and lymphatic filariasis in Central Africa
Joseph Kamgno, Hugues C Nana-Djeunga, Sébastien D Pion, et al.International Health 10 (suppl_1) i49 (2018)
https://doi.org/10.1093/inthealth/ihx051
Case Report: Probable Case of Spontaneous Encephalopathy Due to Loiasis and Dramatic Reduction of Loa loa Microfilariaemia with Prolonged Repeated Courses of Albendazole
Divine B. Arrey-Agbor, Hugues C. Nana-Djeunga, Aude E. Mogoung-Wafo, et al.The American Journal of Tropical Medicine and Hygiene 99 (1) 112 (2018)
https://doi.org/10.4269/ajtmh.17-0664
Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature
Philip J. Budge, Carly Herbert, Britt J. Andersen, Gary J. Weil and Cinzia CantacessiPLOS Neglected Tropical Diseases 12 (5) e0006454 (2018)
https://doi.org/10.1371/journal.pntd.0006454
Absence of Loa loa Microfilaremia among Newly Arrived Congolese Refugees in Texas
Jessica Montour, Deborah Lee, Cathy Snider, Emily S. Jentes and William StaufferThe American Journal of Tropical Medicine and Hygiene 97 (6) 1833 (2017)
https://doi.org/10.4269/ajtmh.17-0337
Effect of Two or Six Doses 800 mg of Albendazole Every Two Months on Loa loa Microfilaraemia: A Double Blind, Randomized, Placebo-Controlled Trial
Joseph Kamgno, Patrick Nguipdop-Djomo, Raceline Gounoue, et al.PLOS Neglected Tropical Diseases 10 (3) e0004492 (2016)
https://doi.org/10.1371/journal.pntd.0004492
Identification and Validation of Loa loa Microfilaria-Specific Biomarkers: a Rational Design Approach Using Proteomics and Novel Immunoassays
Papa M. Drame, Zhaojing Meng, Sasisekhar Bennuru, et al.mBio 7 (1) (2016)
https://doi.org/10.1128/mBio.02132-15
Loa loa—does it deserve to be neglected?
Wolfram Gottfried Metzger and Benjamin MordmüllerThe Lancet Infectious Diseases 14 (4) 353 (2014)
https://doi.org/10.1016/S1473-3099(13)70263-9
Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (∼25μg/kg) versus current standard dose (150μg/kg)
Joseph Kamgno, Sébastien D.S. Pion, Mathurin C. Tejiokem, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene 101 (8) 777 (2007)
https://doi.org/10.1016/j.trstmh.2007.03.018
Loa loa
Patrice BouréeEMC - Biologie Médicale 1 (1) 1 (2006)
https://doi.org/10.1016/S2211-9698(06)76281-1
Médicaments antihelminthiques
X. Bohand, B. Edouard and J. MaslinEMC - Maladies infectieuses 2 (1) 1 (2005)
https://doi.org/10.1016/S1166-8598(05)39259-3
Mapping the distribution of Loa loain Cameroon in support of the African Programme for Onchocerciasis Control
Madeleine C Thomson, Valérie Obsomer, Joseph Kamgno, Jacques Gardon, Samuel Wanji, Innocent Takougang, Peter Enyong, Jan H Remme, David H Molyneux and Michel BoussinesqFilaria Journal 3 (1) (2004)
https://doi.org/10.1186/1475-2883-3-7
Médicaments antihelminthiques
X Bohand, B Edouard and J MaslinEMC - Maladies Infectieuses 1 (3) 221 (2004)
https://doi.org/10.1016/j.emcmi.2004.04.002
Mass drug treatment for lymphatic filariasis and onchocerciasis
David H Molyneux, Mark Bradley, Achim Hoerauf, Dominique Kyelem and Mark J TaylorTrends in Parasitology 19 (11) 516 (2003)
https://doi.org/10.1016/j.pt.2003.09.004
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations
John HortonCurrent Opinion in Infectious Diseases 15 (6) 599 (2002)
https://doi.org/10.1097/00001432-200212000-00008
Effects of a 3-day regimen of albendazole (800 mg daily) onLoa loamicrofilaraemia
L. Tsague-Dongmo, J. Kamgno, S. D. S. Pion, R. Moyou-Somo and M. BoussinesqAnnals of Tropical Medicine & Parasitology 96 (7) 707 (2002)
https://doi.org/10.1179/000349802125001933